Total Payments
$715,090
2024 Payments
$6,188
Companies
39
Transactions
1,280
Medicare Patients
2,688
Medicare Billing
$410,138
Payment Breakdown by Category
Other$282,508 (39.5%)
Consulting$254,626 (35.6%)
Research$82,412 (11.5%)
Travel$68,633 (9.6%)
Food & Beverage$26,912 (3.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $254,626 | 134 | 35.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $119,100 | 48 | 16.7% |
| Compensation for serving as faculty or as a speaker for a medical education program | $82,802 | 59 | 11.6% |
| Unspecified | $82,412 | 304 | 11.5% |
| Travel and Lodging | $68,633 | 259 | 9.6% |
| Current or prospective ownership or investment interest | $42,879 | 3 | 6.0% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $35,357 | 16 | 4.9% |
| Food and Beverage | $26,912 | 454 | 3.8% |
| Debt forgiveness | $2,154 | 2 | 0.3% |
| Honoraria | $217.00 | 1 | 0.0% |
Payments by Type
General
$632,678
976 transactions
Research
$82,412
304 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $395,711 | 612 | $0 (2024) |
| Vertiflex, Inc. | $108,295 | 111 | $0 (2019) |
| MML US, Inc. | $55,266 | 36 | $0 (2024) |
| Nalu Medical, Inc. | $50,101 | 8 | $0 (2024) |
| BIOTRONIK INC. | $38,451 | 286 | $0 (2021) |
| Saluda Medical Americas, Inc. | $26,365 | 55 | $0 (2024) |
| Nevro Corp. | $13,800 | 29 | $0 (2023) |
| Jazz Pharmaceuticals Inc. | $8,729 | 25 | $0 (2018) |
| BOSTON SCIENTIFIC CORPORATION | $7,585 | 6 | $0 (2021) |
| Medtronic, Inc. | $2,171 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,188 | 21 | Abbott Laboratories ($4,167) |
| 2023 | $57,005 | 64 | Abbott Laboratories ($20,662) |
| 2022 | $140,011 | 153 | Abbott Laboratories ($89,349) |
| 2021 | $76,148 | 128 | Abbott Laboratories ($35,214) |
| 2020 | $58,343 | 121 | Abbott Laboratories ($31,983) |
| 2019 | $105,716 | 344 | Abbott Laboratories ($49,997) |
| 2018 | $163,906 | 212 | Abbott Laboratories ($104,120) |
| 2017 | $107,772 | 237 | Abbott Laboratories ($60,218) |
All Payment Transactions
1,280 individual payment records from CMS Open Payments — Page 1 of 52
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $30.19 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/05/2024 | MML US, Inc. | ReActiv8 (Device) | — | Cash or cash equivalent | $1,180.00 | Research |
| Study: Restore • Category: Pain Management | ||||||
| 10/23/2024 | MML US, Inc. | ReActiv8 (Device) | — | Cash or cash equivalent | $390.00 | Research |
| Study: Restore • Category: Pain Management | ||||||
| 10/17/2024 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $59.59 | General |
| 10/16/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $91.11 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/29/2024 | Abbott Laboratories | IONICRF (Device) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Neuromodulation | ||||||
| 07/12/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $80.41 | General |
| Category: RAPID DIAGNOSTICS | ||||||
| 04/26/2024 | TerSera Therapeutics LLC | Prialt (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Pain Management | ||||||
| 02/29/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $29.25 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/16/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $33.48 | General |
| Category: Pain Management | ||||||
| 01/26/2024 | Abbott Laboratories | PROCLAIM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $282.50 | General |
| Category: Neuromodulation | ||||||
| 01/24/2024 | Abbott Laboratories | PROCLAIM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,412.50 | General |
| Category: Neuromodulation | ||||||
| 01/24/2024 | Abbott Laboratories | PROCLAIM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $765.00 | General |
| Category: Neuromodulation | ||||||
| 01/24/2024 | Abbott Laboratories | PROCLAIM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $510.00 | General |
| Category: Neuromodulation | ||||||
| 01/24/2024 | Abbott Laboratories | PROCLAIM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $510.00 | General |
| Category: Neuromodulation | ||||||
| 01/24/2024 | Abbott Laboratories | PROCLAIM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $282.50 | General |
| Category: Neuromodulation | ||||||
| 01/24/2024 | Abbott Laboratories | PROCLAIM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $282.50 | General |
| Category: Neuromodulation | ||||||
| 01/24/2024 | Abbott Laboratories | PROCLAIM (Device) | Travel and Lodging | In-kind items and services | $14.75 | General |
| Category: Neuromodulation | ||||||
| 01/24/2024 | Abbott Laboratories | PROCLAIM (Device) | Travel and Lodging | In-kind items and services | $9.02 | General |
| Category: Neuromodulation | ||||||
| 01/18/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $31.55 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/17/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $161.62 | General |
| Category: Spinal Cord Stimulator | ||||||
| 12/31/2023 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Consulting Fee | Dividend, profit or other return on investment | $7,106.25 | General |
| Category: Pain Management | ||||||
| 12/13/2023 | Abbott Laboratories | PROCLAIM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,520.00 | General |
| Category: Neuromodulation | ||||||
| 12/13/2023 | Abbott Laboratories | PROCLAIM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,570.00 | General |
| Category: Neuromodulation | ||||||
| 12/13/2023 | Abbott Laboratories | PROCLAIM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,825.00 | General |
| Category: Neuromodulation | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| BENEFIT-02 | BIOTRONIK INC. | $29,180 | 281 |
| TARGET: A Post-Approval Study to Evaluate Targeted SCS (DRG) Stimulation for the management of Moderate to Severe Chronic, Intractable, Pain of the Lower Limbs due to CRPS types I and II | Abbott Laboratories | $18,545 | 4 |
| Restore | MML US, Inc. | $17,903 | 6 |
| TARGET A Post-Approval Study to Evaluate Targeted SCS (DRG) Stimulation for the management of Moderate to Severe Chronic Intractable Pain of the Lower Limbs due to CRPS types I and II | Abbott Laboratories | $7,127 | 2 |
| Evoke Study | Saluda Medical Americas, Inc. | $3,656 | 7 |
| PROLONG Prospective, Multi-center, Open-label, Post-market Study (PROLONG) | Abbott Laboratories | $3,000 | 1 |
| TARGET | Abbott Laboratories | $2,167 | 2 |
| Target | Abbott Laboratories | $835.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 764 | 4,938 | $1.2M | $126,494 |
| 2022 | 26 | 738 | 4,075 | $979,878 | $109,519 |
| 2021 | 23 | 610 | 3,134 | $801,113 | $99,413 |
| 2020 | 23 | 576 | 2,745 | $615,485 | $74,712 |
Total Patients
2,688
Total Services
14,892
Medicare Billing
$410,138
Procedure Codes
98
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 72 | 261 | $136,563 | $29,771 | 21.8% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 89 | 379 | $41,241 | $18,832 | 45.7% |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2023 | 89 | 391 | $41,837 | $18,689 | 44.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 55 | 55 | $55,672 | $10,154 | 18.2% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 14 | 527 | $225,556 | $9,469 | 4.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 14 | 136 | $145,520 | $7,793 | 5.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 91 | $34,080 | $5,719 | 16.8% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 15 | 18 | $73,188 | $4,912 | 6.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 26 | $18,333 | $4,196 | 22.9% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2023 | 35 | 83 | $7,105 | $3,170 | 44.6% |
| 96368 | Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | Office | 2023 | 13 | 132 | $84,744 | $2,269 | 2.7% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 13 | 18 | $73,188 | $2,123 | 2.9% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 15 | 153 | $65,484 | $2,047 | 3.1% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 26 | 151 | $7,271 | $1,804 | 24.8% |
| 76882 | Limited ultrasound scan of joint or other extremity structure except blood vessels | Office | 2023 | 13 | 31 | $16,585 | $1,186 | 7.1% |
| J3415 | Injection, pyridoxine hcl, 100 mg | Office | 2023 | 13 | 125 | $4,013 | $1,086 | 27.1% |
| J0735 | Injection, clonidine hydrochloride, 1 mg | Office | 2023 | 12 | 63 | $10,112 | $1,030 | 10.2% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 13 | 20 | $32,100 | $1,006 | 3.1% |
| 97760 | Training in the use of orthopedic device for arm, leg and/or trunk, each 15 minutes | Office | 2023 | 11 | 12 | $2,568 | $529.92 | 20.6% |
| J3475 | Injection, magnesium sulfate, per 500 mg | Office | 2023 | 13 | 414 | $8,860 | $244.45 | 2.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 23 | 241 | $12,894 | $200.74 | 1.6% |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 2023 | 48 | 409 | $21,882 | $135.61 | 0.6% |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | Office | 2023 | 19 | 512 | $10,957 | $35.84 | 0.3% |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | Office | 2023 | 24 | 306 | $13,097 | $35.27 | 0.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 43 | 352 | $7,533 | $34.46 | 0.5% |
About Dr. Corey Hunter, M.D
Dr. Corey Hunter, M.D is a Interventional Pain Medicine healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/16/2008. The National Provider Identifier (NPI) number assigned to this provider is 1194999532.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Corey Hunter, M.D has received a total of $715,090 in payments from pharmaceutical and medical device companies, with $6,188 received in 2024. These payments were reported across 1,280 transactions from 39 companies. The most common payment nature is "Consulting Fee" ($254,626).
As a Medicare-enrolled provider, Hunter has provided services to 2,688 Medicare beneficiaries, totaling 14,892 services with total Medicare billing of $410,138. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Pain Medicine
- Other Specialties Pain Medicine
- Location New York, NY
- Active Since 04/16/2008
- Last Updated 12/14/2015
- Taxonomy Code 208VP0014X
- Entity Type Individual
- NPI Number 1194999532
Products in Payments
- Superion ISS (Device) $108,295
- PROCLAIM (Device) $79,648
- Axium INS DRG IPG (Device) $70,537
- ReActiv8 (Device) $55,266
- Neuromodulation Dspsbls and Accs (Device) $54,860
- Nalu Neurostimulation System (Device) $50,101
- DRG leads (Device) $39,101
- Proclaim Family of SCS IPGs (Device) $25,053
- Evoke SCS (Device) $22,456
- Axium and Proclaim Neurostimulator Systems (Device) $18,545
- IonicRF Generator (Device) $17,691
- SCS IPGs (Device) $16,207
- Senza Spinal Cord Stimulation System (Device) $13,710
- Proclaim IPG (Device) $11,462
- Prialt (Drug) $8,743
- Neuromodulation-Research Only (Device) $7,983
- Proclaim DRG IPG (Device) $4,713
- SUPERION (Device) $4,543
- Evoke (Device) $3,908
- Superion (Device) $3,012
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Pain Medicine Doctors in New York
Dr. Neel Mehta, Md, MD
Interventional Pain Medicine — Payments: $532,025
Interventional Pain Medicine $532,025
Gerard Degregoris, M.d, M.D
Interventional Pain Medicine — Payments: $357,088
Interventional Pain Medicine $357,088
Suelane Do Ouro, Md, MD
Interventional Pain Medicine — Payments: $80,187
Interventional Pain Medicine $80,187
Dr. Barthelemy Liabaud, M.d, M.D
Interventional Pain Medicine — Payments: $18,863
Interventional Pain Medicine $18,863
Dr. Jason Siefferman, M.d, M.D
Interventional Pain Medicine — Payments: $14,429
Interventional Pain Medicine $14,429
Jeffrey Deygoo, M.d, M.D
Interventional Pain Medicine — Payments: $10,608
Interventional Pain Medicine $10,608